Maria Sainz's most recent trade in Hyperfine Inc - Ordinary Shares - Class A was a trade of 1,435,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 28, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hyperfine Inc - Ordinary S... | Sainz Maria | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 1,435,000 | 1,435,000 | - | - | Stock Option (right to buy) | |
| ShockWave Medical Inc | Maria Sainz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 736 | 5,328 (0%) | 0% | 0 | Common Stock | |
| ShockWave Medical Inc | Maria Sainz | Director | Sale of securities on an exchange or to another person at price $ 193.00 per share. | 23 Feb 2023 | 724 | 4,592 (0%) | 0% | 193 | 139,732 | Common Stock |
| Hyperfine Inc - Ordinary S... | Maria Sainz | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 14 Dec 2022 | 5,000 | 39,425 | - | 1.0 | 4,750 | Class A Common Stock |
| Hyperfine Inc - Ordinary S... | Maria Sainz | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 09 Dec 2022 | 12,425 | 34,425 | - | 0.8 | 10,561 | Class A Common Stock |
| Hyperfine Inc - Ordinary S... | Maria Sainz | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 08 Dec 2022 | 2,575 | 22,161 | - | 0.8 | 2,137 | Class A Common Stock |
| Hyperfine Inc - Ordinary S... | Maria Sainz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 3,175,000 | 3,175,000 | - | - | Stock Option (right to buy) | |
| ShockWave Medical Inc | Maria Sainz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 994 | 5,966 (0%) | 0% | 0 | Common Stock | |
| Hyperfine Inc - Ordinary S... | Maria Sainz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 85,345 | 85,345 | - | - | Stock Options (right to buy) | |
| Atrion Corp. | Maria Sainz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 172 | 284 (0%) | 0% | 0 | Common Stock | |
| Avanos Medical Inc | Maria Sainz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 5,354 | 33,396 (0%) | 0% | 0 | Common Stock | |
| Atrion Corp. | Maria Sainz | Director | Grant, award, or other acquisition of securities at price $ 704.89 per share. | 03 Jan 2022 | 18 | 112 (0%) | 0% | 704.9 | 12,688 | Common Stock |
| Hyperfine Inc - Ordinary S... | Maria Sainz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2021 | 19,586 | 19,586 | - | 0 | Class A Common Stock | |
| Atrion Corp. | Maria Sainz | Director | Grant, award, or other acquisition of securities at price $ 703.63 per share. | 30 Aug 2021 | 94 | 94 (0%) | 0% | 703.6 | 66,141 | Common Stock |
| Avanos Medical Inc | Maria Sainz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 4,005 | 28,042 (0%) | 0% | 0 | Common Stock | |
| ShockWave Medical Inc | Maria Sainz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 4,122 | 4,122 (0%) | 0% | 0 | Common Stock |